Abstract:Background: Solanum nigrum L. (SNL) (Longkui) is a Chinese herb that can be used to treat colon cancer. The present study explored the components and mechanisms of SNL in treating colon cancer by using network pharmacology and molecular docking. Methods: The components of SNL were collected from the TCMSP, ETCM, HERB, and NPASS databases. Meanwhile, the target proteins of these ingredients were collected/predicted by the TCMSP, SEA, SwissTargetPrediction, and the STITCH databases colon cancer-related target genes were identified from TCGA and GTEx databases. The interaction networks were established via Cytoscape 3.7.2. Gene Ontology and KEGG pathways were enriched by using the David 6.8 online tool. Finally, the binding of key components and targets was verified by molecular docking, and the cellular thermal shift assay (CETSA) was used to detect the efficiency of apigenin and kaempferol binding to the AURKB protein in CT26 cells. Results: A total of 37 SNL components, 796 SNL targets, 5,356 colon cancer genes, and 241 shared targets of SNL and colon cancer were identified. A total of 43 key targets were obtained through topology analysis. These key targets are involved in multiple biological processes, such as signal transduction and response to drug and protein phosphorylation. At the same time, 104 signaling pathways, such as pathways in cancer, human cytomegalovirus infection, and PI3K-Akt signaling pathway, are also involved. The binding of the four key components (i.e., quercetin, apigenin, kaempferol, and luteolin) and the key targets was verified by molecular docking. The CETSA results showed that apigenin and kaempferol were able to bind to the AURKB protein to exert anti-CRC effects. Conclusions: Quercetin, apigenin, kaempferol, and luteolin are the main components of SNL in treating colon cancer. SNL regulates multiple bioprocesses via signaling pathways, such as pathways in cancer, PI3K-Akt, and cell cycle signaling pathways.

Bioactive compounds isolated from Solanum nigrum remarkably inhibit cancerous activity in cancer cell lines

Steroidal alkaloids from Solanum nigrum and their cytotoxic activities

Active components of Solanum nigrum and their antitumor effects: a literature review

Emerging themes of regulation of oncogenic proteins by Solanum nigrum and its bioactive molecules in different cancers

Ripe fruit of Solanum nigrum L. inhibits cell growth and induces apoptosis in MCF-7 cells

[Review about Mechanisms of Anti-Cancer of Solanum Nigrum].

Main chemical constituents and mechanism of anti‐tumor action of Solanum nigrum L

Anticancer Activity Of Steroid Alkaloids Isolated From Solanum Aculeastrum

Probing the mechanism of action (MOA) of Solanum nigrum Linn against breast cancer using network pharmacology and molecular docking

Anticancer L-Asparaginase and Phytoactive Compounds From Plant Solanum nigrum Against MDR (Methicillindrug resistant) Staphylococcus aureus and Fungal Isolates

Solanum nigrum Linn.: Advances in anti-cancer activity and mechanism in digestive system tumors

Separation of major bioactive components by GC-MS and antioxidant studies on Solanum nigrum extract

Antiproliferative Effects of Methanolic Fruit Extract of Solanum xenthocarpum (L.) on Human Breast Cancer Cells

Anticancer activity of glycoalkaloids from Solanum plants: A review

Steroidal constituents from Solanum nigrum

Unleashed Treasures of Solanaceae: Mechanistic Insights into Phytochemicals with Therapeutic Potential for Combatting Human Diseases

New Solasodine‐type Glycoalkaloids Isolated from Solanum nigrum and Their Cytotoxic Activity

Alpha Solanine: A Novel Natural Bioactive Molecule with Anticancer Effects in Multiple Human Malignancies

Purification, antitumour and immunomodulatory activity of water-extractable and alkali-extractable polysaccharides from Solanum nigrum L.

In vitro and in silico study of eggplant extract on human cancer cell lines

Exploring the components and mechanism of Solanum nigrum L. for colon cancer treatment based on network pharmacology and molecular docking